ArticleCancers2022

Combinations of ATR, Chk1 and Wee1 Inhibitors with Olaparib Are Active in Olaparib Resistant

Michela Chiappa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.